Smithfield Trust CO Horizon Therapeutics Public LTD CO Transaction History

Smithfield Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $39,708 - $41,995	-370 Reduced 94.87%	20 $2,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $112,065 - $161,042	-1,902 Reduced 82.98%	390 $25,000
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $1,588 - $2,327	-20 Reduced 0.87%	2,292 $183,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $1,379 - $1,678	-14 Reduced 0.6%	2,312 $249,000
Q2 2021 Jul 26, 2021	SELL	$86.24 - $95.92 $1,724 - $1,918	-20 Reduced 0.85%	2,326 $218,000

Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $125,127 - $166,326	1,742 Added 288.41%	2,346 $215,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $33,358 - $48,277	604 New	604 $47,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

Stay updated on Smithfield Trust CO with notifications on news.